PATRUNO, Cataldo
 Distribuzione geografica
Continente #
NA - Nord America 11.721
EU - Europa 9.974
AS - Asia 3.367
SA - Sud America 2.026
AF - Africa 326
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 27.432
Nazione #
US - Stati Uniti d'America 11.422
RU - Federazione Russa 7.866
BR - Brasile 1.653
SG - Singapore 1.305
VN - Vietnam 649
IE - Irlanda 633
CN - Cina 395
IT - Italia 270
GB - Regno Unito 181
DE - Germania 176
HK - Hong Kong 176
UA - Ucraina 164
CI - Costa d'Avorio 163
FI - Finlandia 147
SE - Svezia 142
IN - India 136
AR - Argentina 134
CA - Canada 133
MX - Messico 122
BD - Bangladesh 103
ID - Indonesia 99
TH - Thailandia 93
FR - Francia 87
EC - Ecuador 83
JP - Giappone 80
NL - Olanda 66
ZA - Sudafrica 65
PL - Polonia 61
TR - Turchia 50
ES - Italia 46
AT - Austria 45
CO - Colombia 45
IQ - Iraq 42
CL - Cile 31
MY - Malesia 27
VE - Venezuela 27
MA - Marocco 26
LT - Lituania 23
PH - Filippine 23
SA - Arabia Saudita 23
PY - Paraguay 20
EG - Egitto 19
UZ - Uzbekistan 19
PK - Pakistan 18
JO - Giordania 17
BE - Belgio 16
AE - Emirati Arabi Uniti 15
KE - Kenya 14
OM - Oman 14
UY - Uruguay 14
IR - Iran 13
PE - Perù 13
IL - Israele 12
TN - Tunisia 12
AZ - Azerbaigian 10
KR - Corea 8
AL - Albania 7
BG - Bulgaria 7
JM - Giamaica 7
KZ - Kazakistan 7
NP - Nepal 7
AU - Australia 6
BO - Bolivia 6
CR - Costa Rica 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
SN - Senegal 5
AM - Armenia 4
DK - Danimarca 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
ET - Etiopia 4
EU - Europa 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
GR - Grecia 3
HN - Honduras 3
HR - Croazia 3
KG - Kirghizistan 3
KW - Kuwait 3
LB - Libano 3
MT - Malta 3
PA - Panama 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EE - Estonia 2
GH - Ghana 2
GT - Guatemala 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TW - Taiwan 2
Totale 27.406
Città #
Dallas 7.634
Moscow 2.661
Singapore 890
Dublin 633
Chandler 497
Ashburn 434
Jacksonville 283
Ho Chi Minh City 272
The Dalles 237
Beijing 217
New York 184
Hong Kong 173
Abidjan 163
São Paulo 162
Los Angeles 161
Helsinki 142
Hanoi 140
Wilmington 76
Tokyo 71
San Mateo 69
Mexico City 66
Princeton 65
Brooklyn 58
Assago 56
Warsaw 55
Bangkok 54
Rio de Janeiro 51
Jakarta 50
London 50
Munich 48
San Francisco 48
Montreal 42
Vienna 42
Curitiba 41
Santa Clara 40
Johannesburg 39
Ann Arbor 36
Atlanta 36
Belo Horizonte 35
Chicago 35
Denver 33
Orem 33
Stockholm 33
Guayaquil 32
Boardman 31
Phoenix 31
Boston 29
Haiphong 29
Chennai 28
Porto Alegre 28
Toronto 28
Ankara 26
Falkenstein 26
Poplar 24
Brasília 23
Columbus 23
Mumbai 21
Quito 21
Rome 21
Amsterdam 20
Chiang Mai 20
Dhaka 20
Salvador 20
Manchester 19
Tashkent 19
Thái Bình 19
Campinas 18
Dearborn 18
Manila 18
Seattle 18
Amman 17
Baghdad 17
Cape Town 17
Da Nang 17
Redwood City 17
Biên Hòa 16
Frankfurt am Main 16
Houston 16
Kuala Selangor 16
Naples 16
Ribeirão Preto 16
Charlotte 15
Goiânia 15
Guarulhos 15
Jinan 15
Milan 14
New Delhi 14
Querétaro 14
Brussels 13
Nairobi 13
Bogotá 12
Caxias do Sul 11
Hải Dương 11
Kuala Lumpur 11
Ninh Bình 11
Fortaleza 10
Istanbul 10
Manaus 10
Ottawa 10
Recife 10
Totale 17.190
Nome #
Cost-effectiveness Analysis of Dupilumab for the Treatment of Adult Patients with Severe Prurigo Nodularis in Italy 848
The Use of JAK Inhibitors in Elderly Patients with Moderate-to-Severe Atopic Dermatitis: A Narrative Review of Clinical and Real-World Evidence 847
Clinical perspectives on prurigo nodularis: diagnostic challenges and novel treatment options 798
Real-world effectiveness of lebrikizumab on pruritus in moderate-to-severe atopic dermatitis: preliminary data from a single-center, real-life experience 774
The Impact of Vitiligo on Patients' Quality of Life: Retrospective Observational Study 749
Incidence, Risk Factors, and Management of Conjunctivitis in Atopic Dermatitis Patients Treated With Dupilumab or Tralokinumab: Results From a Multicenter, Observational, Retrospective Study 695
A Rare Case of Methotrexate Photoreactivation Reaction 603
Topical erythromycin in atopic dermatitis 320
The use of protective gloves by Italian housewife 215
An Italian multicentre study on adult atopic dermatitis: persistent versus adult-onset disease 187
ALLERGIC CONTACT DERMATITIS PROBABLY DUE TO LATANOPROST DURING TREATMENT FOR ALOPECIA AREATA. 181
Adult atopic dermatitis: A review 178
Acrodermatitis continua of Hallopeau (ACH): Two cases successfully treated with adalimumab 172
Managing moderate-to-severe psoriasis in the elderly 162
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis 161
Eczematous eruption during anti-interleukin 17 treatment of psoriasis: an emerging condition. 158
Maladie de Crohn 156
Angiokeratoma corporea diffusamente (Fabry's disease) 155
Psoriasis and high school students: An educational approach 151
Adult atopic dermatitis: new and emerging therapies 151
Psoriasis in elderly and non-elderly population: Clinical and molecular features 149
Systemic Treatment of Adult Atopic Dermatitis: A Review 148
Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation 145
What's new about atopic dermatitis and sporting activity 145
Aryl hydrocarbon receptor (AhR) a possible target for the treatment of skin disease 144
Garbage and skin diseases related risk 142
A case of dirty neck in severe and diffuse atopic dermatitis successfully treated with dupilumab 142
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 140
Dupilumab and COVID-19: what should we expect? 139
Biologics for psoriasis in COVID-19 era: what do we know? 134
Systemic treatment for psoriasis and malignancies: A real risk? 133
Multicenter clinical trial on a permanent hair dye containing paratoluenediamine 133
Urticaria: Recommendations from the Italian Society of Allergology, Asthma and Clinical Immunology and the Italian Society of Allergological, Occupational and Environmental Dermatology 131
Four-week urticaria activity score-7 as a useful patient-reported outcome to assess chronic spontaneous urticaria: A multicentre study evaluation of adherence and patients’ perspective 131
Aquagenic wrinkling of the palms 130
Occupational allergic contact dermatitis to acrylic fingernails in beauticians 129
Skin tests in the diagnosis of adverse drug reactions 129
DECISA Project (DErmatology Clinics in Italy: Survey on Alitretinoin): a real-life retrospective cohort multicentre study on 438 subjects with chronic hand eczema 128
Periungual and subungual pyogenic granuloma following anti-TNF-α therapy: Is it the first case? 127
Chronic inducible urticarias in children. 127
Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study 127
Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study 127
Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study 127
Skin diseases and tattoos: A five-year experience 124
Eyelid dermatitis and contact sensitization to nickel: Results from an italian multi-centric observational study 123
I cambiamenti climatici possono influenzare le patologie dermatologiche? Orticaria papulosa e clima: Contributo casistico 122
A case of type 3 familial hyperlipoproteinemia 121
Patch test and scratch patch test with tumor necrosis factor-alpha inhibitors 120
Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults 119
A case of allergic contact dermatitis due to implantable cardioverter-defibrillator 118
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 116
Contact sensitivity to electrocardiogram electrodes due to acrylic acid: A rare cause of medical device allergy 115
Italian guidelines for therapy of atopic dermatitis-Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) 113
Profile of baricitinib and its potential in the treatment of moderate to severe atopic dermatitis: A short review on the emerging clinical evidence 112
Abrocitinib in atopic dermatitis: review of the current literature and clinical trials 112
Contact allergy to 3-dimethylaminopropylamine in 5140 consecutive Italian patients: A one-year retrospective multicenter SIDAPA study 110
Acne and allergic contact dermatitis 109
Psoriasis and sport: A new ally? 104
Salt-dependent aquagenic urticaria in children: Report of two cases 103
Prevalence of Chronic Inducible Urticaria in Elderly Patients 103
A 24-weeks real-world experience of dupilumab in adolescents with moderate-to-severe atopic dermatitis 102
A case of aquagenic wrinkling of the hands 101
A study to evaluate the efficacy of a moisturizing and lenitive emulsion for the treatment of xerotic skin 99
The SIDAPA guidelines on contact dermatitis 97
The Role of Thermal Water in Chronic Skin Diseases Management: A Review of the Literature 96
A case of adult scrotal oedema probably induced by the interaction between lacidipine and clarithromycin 94
A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis 93
IL-26: a new actor in allergic contact dermatitis 93
Psoriasis in melanoma patients: A prospective pilot study 93
Treatment of Atopic Dermatitis with Biologic Drugs 92
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years 91
Effectiveness of Dupilumab for the Treatment of Generalized Prurigo Nodularis Phenotype of Adult Atopic Dermatitis 91
Corrigendum to: Allergic contact dermatitis from rifamycin (Contact Dermatitis, (1988), 19, 4, (310), 10.1111/j.1600-0536.1988.tb02937.x) 90
Chronic urticaria can be caused by cancer and resolves with its cure 90
A novel vehicle for the treatment of psoriasis 89
Hypersensitivity reaction to certolizumab pegol in a patient affected by psoriatic arthritis 88
A 52‐week update of a multicentre Italian real‐world experience on effectiveness and safety of dupilumab in adolescents with moderate to severe atopic dermatitis 87
Eczematous reaction to ixekizumab successfully treated with dupilumab 87
A multicentric study on prevalence of clinical patterns and clinical phenotypes in adult atopic dermatitis 86
Various Identification of textile dyes by laboratory methods 86
Cutaneus sarcoidosis small-fiber neuropathy resembling leprosy: a case report 86
New emergent therapies for atopic dermatitis: A review of safety profile with respect to female fertility, pregnancy, and breastfeeding 86
A practical guide to recognize allergic and immunologic skin diseases: diagnosis at first sight 85
Is climate change the next pandemic for dermatology? Lessons from COVID-19 85
Vibratory angioedema 84
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 80
A multicentre study of contact sensitization in children 79
Paracetamol-induced symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) in a psoriasis patient receiving apremilast therapy 75
Etanercept for pediatric acrodermatitis continua of Hallopeau: A case report and literature review 75
Clinical phenotypes of atopic dermatitis of the adult 73
Vitamin D and psoriasis: an update for dermatologists and nutritionists 72
Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre 71
Postinflammatory hypopigmentation due to ferrous sulphate 70
The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data 69
Safety of dupilumab in atopic patients during COVID-19 outbreak 68
"Eczemas" and leptin 67
Reply: Potential role of Janus kinase inhibitors in COVID-19 66
Dermoscopic assessment of long-term systemic therapy with dupilumab in adult atopic dermatitis 65
Letter: Atopic Dermatitis, 2-HEMA Allergic Contact Dermatitis, and Chemical Leukoderma: Which Relationship? 64
Efficacy and Safety of Tralokinumab in Real Life: Possible Predictive Rapid Response Factors 62
Totale 16.039
Categoria #
all - tutte 106.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.107


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 31 51 8 63 10 91 5
2021/2022372 7 74 10 7 44 24 2 42 75 37 28 22
2022/20231.668 205 99 31 146 74 135 8 87 774 62 22 25
2023/2024259 75 45 22 11 12 54 7 4 0 7 1 21
2024/20253.792 182 38 93 7 185 43 844 174 263 170 700 1.093
2025/202620.920 793 2.734 6.250 1.766 5.518 3.859 0 0 0 0 0 0
Totale 27.963